Find More Contacts for Illumina
Protected Content
President
Non-Management, Executive Management
2 phone numbers found
View contacts for Illumina to access new leads and connect with decision-makers.
View All Contacts

Details

Edit Details Section
  • Investor Type  Accelerator
  • Investment Stage  Early Stage Venture, Late Stage Venture
  • Number of Exits 
    7
  • Contact Email info@illumina.com
  • Phone Number 858.202.4500

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and

complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.

Lists Featuring This Company

Edit Lists Featuring This Company Section
Biotechnology Companies With More Than 100 Employees
5,570 Number of Organizations • $667.7B Total Funding Amount • 13,240 Number of Investors
United States Late Stage Venture Investors
3,765 Number of Organizations • $87.1B Total Funding Amount • 754 Number of Investors
Tufts University Alumni Founded Companies
29 Number of Organizations • $3.8B Total Funding Amount • 98 Number of Investors
Early Stage Venture Investors with Investments in Greater Denver Area
2,229 Number of Organizations • $48B Total Funding Amount • 663 Number of Investors

IPO & Stock Price

Edit IPO & Stock Price Section
Illumina is registered under the ticker NASDAQ:ILMN . Their stock opened with $16.00 in its Aug 1, 2000 IPO.
  • Stock Symbol  NASDAQ:ILMN
  • Money Raised at IPO $96M
  • IPO Share Price $16.00
  • IPO Date Aug 1, 2000
Stock chart by

Sub-Organizations

Edit Sub-Organizations Section
Number of Sub-Orgs 2
Which industries do these Sub-Organization operate in?